Posted in | News

Matisse Networks Receive Patent for Optical Burst Receiver

Matisse Networks, pioneer in the field of optical burst switching (OBS) and the unique EtherBurst® packet WDM system, announced today that it has been awarded a patent (U.S. Patent No. 7,436,920 B2) on optical burst receiver technology that provides key functionality for optical burst switching. The patent covers an innovation on receiving optical burst transmissions using a charge pump PLL with loop stabilization to improve the reliability and performance of the receive function of the optical burst transponder.

“This patent is an important achievement for Matisse, as it protects a part of the core intellectual property in our EtherBurst optical burst switching solution,” said Claude Hamou, Matisse Networks’ Chief Operating Officer. Hamou continued, “We’ve made a significant breakthrough in optical burst technology that has broad applicability in WDM optical transport networks and other applications.”

The patent is the latest of a number of patents have been awarded to Matisse for innovations in the field of Optical Burst Switching (OBS). The earlier patents issued to Matisse cover innovations including synchronization of burst transmitters and bandwidth reservation capabilities within the optical burst network domain. This latest patent pertains to technology that enables reliably receiving optical burst traffic. Currently, Matisse uses the technology in its 10Gbps eBurst™ optical burst module. The eBurst module is a core component of the EtherBurst SX-1000 switch node which supports a variety of telecommunication services and enterprise applications.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.